CEP
BIVV

Chicago Equity Partners’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Chicago Equity Partners’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-9,590
Closed -$517K – 849
2017
Q4 		$517K Buy
9,590
+270
+3% +$14.8K 0.02% 610
2017
Q3 		$532K Buy
9,320
+5,870
+170% +$344K 0.02% 612
2017
Q2 		$208K Buy
+3,450
New +$196K 0.01% 727

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Chicago Equity Partners's BIVV Position: Q1 2018 in Review

Chicago Equity Partners sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 9,590 shares — an estimated $517K sold.

Chicago Equity Partners first reported a position in BIVV in Q2 2017 and held it in 3 quarters. The position peaked at $532K in Q3 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • Chicago Equity Partners reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Chicago Equity Partners sold 9,590 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $517K.
  • Chicago Equity Partners first reported a position in Bioverativ Inc. Common Stock in Q2 2017 and held it in 3 quarters.
  • Chicago Equity Partners's Bioverativ Inc. Common Stock position peaked at $532K in Q3 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Chicago Equity Partners's 13F filing for Q1 2018, filed 7 May 2018.